Back
Grace Therapeutics Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
39
GRCE
Grace Therapeutics
Last Price:
3.08
Seasonality Move:
7.4%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeGrace Therapeutics Price Quote
$3.08
-0.05 (-0.65%)
(Updated: November 5, 2024 at 2:44 AM ET)
Grace Therapeutics Key Stats
Sell
39
Grace Therapeutics (GRCE)
is a Sell
Day range:
$3.01 - $3.26
52-week range:
$1.98 - $3.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.54%
Volume:
12K
Avg. volume:
45.8K
1-year change:
30.63%
Market cap:
$31.8M
Revenue:
$0
EPS:
$-1.42
How Much Does Grace Therapeutics Make?
Data Unavailable
Is Grace Therapeutics Growing As A Company?
Data Unavailable
Grace Therapeutics Stock Price Performance
-
Did Grace Therapeutics Stock Go Up Last Month?
Grace Therapeutics share price went up by 0.8% last month -
Did GRCE's Share Price Rise Over The Last Year?
GRCE share price rose by 30.63% over the past 1 year
What Is Grace Therapeutics 52-Week High & Low?
-
What Is Grace Therapeutics’s 52-Week High Share Price?
Grace Therapeutics has traded as high as $3.60 over the past 52 weeks -
What Is Grace Therapeutics’s 52-Week Low Share Price?
Grace Therapeutics has traded as low as $1.98 over the past 52 weeks
Grace Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Grace Therapeutics?
-
How Much Debt Does Grace Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Grace Therapeutics Have?
Cash and short term investments quarterly total is $19.4M -
What Is Grace Therapeutics’s Book Value Per Share?
Book value per share is 5.85
Is Grace Therapeutics Cash Flow Positive?
-
What Is GRCE Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.7M -
What Is Grace Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Grace Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $89K
Grace Therapeutics Return On Invested Capital
Data Unavailable
Grace Therapeutics Earnings Date & Stock Price
-
What Is Grace Therapeutics's Stock Price Today?
A single share of GRCE can be purchased today for 3.14 -
What Is Grace Therapeutics’s Stock Symbol?
Grace Therapeutics trades on the nasdaq under the ticker symbol: GRCE -
When Is Grace Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Grace Therapeutics is scheduled on November 13, 2024 -
When Is GRCE's next ex-dividend date?
Grace Therapeutics's next ex-dividend date is November 5, 2024 -
How To Buy Grace Therapeutics Stock?
You can buy Grace Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Grace Therapeutics Competitors
-
Who Are Grace Therapeutics's Competitors?
Below is a list of companies who compete with Grace Therapeutics or are related in some way:
Grace Therapeutics Dividend Yield
-
What Is GRCE Dividend Yield?
Grace Therapeutics’s dividend yield currently is 0% -
What Is Grace Therapeutics’s Payout Ratio?
Grace Therapeutics’s payout ratio is 0% -
When Did Grace Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Grace Therapeutics’s Dividend Per Share?
Grace Therapeutics pays a dividend of $0.00 per share
Grace Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 9.37% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 10.03 |
| Upside from Last Price: | 219.96% |